Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M

What we doOur approachPipelineTechnologyPatient Stories
About usManagementBoardClinical Advisory BoardCareers
Newsroom
InvestorsPress releases

Back
Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M
 6:00:30 PM

Keep reading
Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018Read